OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

Harnessing big data and AI to combat colorectal cancer

In the rapidly evolving field of oncology, the integration of big data and artificial intelligence is revolutionizing our approach to cancer research and treatment. The future of precision oncology requires integrating computational approaches with clinical practice.

May 23, 2025

Vol.51 No.20

By Enrique Velazquez Villarreal

Clinical

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

When Kelly Spill was eight months pregnant, she experienced some constipation and noticed blood in her stool. Her OBGYN wasn’t worried.

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped responding to chemotherapy, according to a phase III clinical trial by researchers at City of Hope.

May 02, 2025

Vol.51 No.17

Guest Editorial

Regulation must keep up with scientific advances

The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

April 25, 2025

Vol.51 No.16

By Richard M. Goldberg

Clinical Roundup

Disasters likely delay early cancer diagnoses, study shows

Rates of colorectal cancer diagnoses dropped during and shortly after Hurricanes Irma and Maria and the COVID-19 pandemic in Puerto Rico, according to a recent analysis led by investigators at the University of Puerto Rico.

April 18, 2025

Vol.51 No.15

In Brief

CRUK and partners pledge £5.5m funding for colorectal cancer research

Cancer Research UK and partners on March 31 committed £5.5 million in funding to form a research team tasked with making personalized medicine a reality for people with colorectal cancer. The initiative is designed to unite research expertise and solve unanswered questions about the disease.

April 04, 2025

Vol.51 No.13

OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

YOU MAY BE INTERESTED IN

Harnessing big data and AI to combat colorectal cancer

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

Regulation must keep up with scientific advances

Disasters likely delay early cancer diagnoses, study shows

CRUK and partners pledge £5.5m funding for colorectal cancer research

Renew today!

Subscriber content

Never miss an issue!

Login

OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

YOU MAY BE INTERESTED IN

Harnessing big data and AI to combat colorectal cancer

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

Regulation must keep up with scientific advances

Disasters likely delay early cancer diagnoses, study shows

CRUK and partners pledge £5.5m funding for colorectal cancer research

Never miss an issue!

Login

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child